Topical Treatments with Pimecrolimus, Tacrolimus and Medium- to High-Potency Corticosteroids, and Risk of Lymphoma

Publisher： Karger

E-ISSN： 1421-9832|219|1|7-21

ISSN： 1018-8665

Source： Dermatology, Vol.219, Iss.1, 2009-03, pp. : 7-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Facial Flush Reaction after Alcohol Ingestion during Topical Pimecrolimus and Tacrolimus Treatment

By  

Dermatology, Vol. 218, Iss. 1, 2008-10 ,pp. : 71-72

Karger

Access to resources Recommend Favorite

Clinical and Cytological Effects of Pimecrolimus Cream 1% after Resolution of Active Atopic Dermatitis Lesions by Topical Corticosteroids: A Randomized Controlled Trial

By  

Dermatology, Vol. 222, Iss. 1, 2010-12 ,pp. : 36-48

Karger

Access to resources Recommend Favorite

Repigmentation of Vitiligo with Topical Tacrolimus

By  

Dermatology, Vol. 205, Iss. 3, 2002-10 ,pp. : 301-303

Karger

Access to resources Recommend Favorite

Lichen Amyloidosis Improved by 0.1% Topical Tacrolimus

By  

Dermatology, Vol. 205, Iss. 4, 2002-12 ,pp. : 420-421

Karger

Access to resources Recommend Favorite

Topical Tacrolimus for Atopic Dermatitis: Euphoria and Vigilance

By  

Dermatology, Vol. 203, Iss. 1, 2001-09 ,pp. : 1-2

Karger

Access to resources Recommend Favorite